Hadassah

Hadassah Responds to New York Times Op-Ed on BRCA Gene Testing

Monday, Oct 5 2015

The following Letter to the Editor was published in the NY Times digital edition in response to a mention of Hadassah in an article published on September 25, 2015.

To the Editor:

As a two-time breast cancer survivor, I have nothing but compassion for Elizabeth Wurtzel's situation. However, I was troubled to see how Hadassah's position was characterized.

Earlier this year, Dr. Asher Salmon, an oncologist and deputy director of Hadassah Hospital Ein Kerem in Jerusalem, publicly renounced universal BRCA testing for women starting at age 30. He said that the results of BRCA testing alone, without genetic counseling and extensive analysis of family history, do not provide women with the complete picture needed to make an intelligent decision regarding treatment.

"Women with a family history of breast cancer should be tested — maybe as early as age 25 — but the majority of women never have to be tested," said Dr. Salmon. "We shouldn't be practicing one-size-fits-all medicine, but rather medicine with appropriate protocols, guidelines and individualized treatment based on patients' personal histories."

Dr. Salmon's positions represent the consensus in the medical industry. Hadassah believes one thing above all: Choosing a breast cancer screening is a decision that should be made on the basis of science, family history and the informed views of experts.

MARCIE NATAN
New York

The writer is national president of Hadassah, the Women’s Zionist Organization of America.

 

Read the full published responses.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Thursday, Sep 1 2016

Research in Service to Humanity: Hadassah’s DNA

How can we stop the lethal recurrence of melanoma? How can we prevent a fatal heart-valve disorder from occurring?

READ MORE ›
alt_text

Tuesday, Aug 30 2016

Waking up to a New Diagnosis: Sleep Apnea During Pregnancy

While approximately one quarter of pregnant women may suffer from Obstructive Sleep Apnea (OSA), this recurrent cessation or limitation of normal breathing is typically not diagnosed or treated, report Hadassah Medical Organization’s Prof. Yehuda Ginosar, Director of its Mother and Child Anesthesia Unit, and Dr. Suzanne Karan, Associate Professor of Anesthesiology and Director of the Anesthesiology Respiratory Physiology Laboratory at the University of Rochester (NY) School of Medicine. To address the problem, they have proposed a new diagnostic entity called “Gestational Sleep Apnea” to parallel the diagnoses of Gestational Hypertension and Gestational Diabetes--two other complications of pregnancy. With the creation of this new diagnosis, Prof. Ginosar says, “health professionals will be able to properly describe, diagnose, and treat OSA in pregnant women.”

READ MORE ›
alt_text

Wednesday, Aug 24 2016

Foreign Volunteers Prove Major Asset at Hadassah’s Institute of Oncology

Although the Hadassah Medical Organization’s hospitals in Ein Kerem and on Mount Scopus are grateful for their hundreds of Israeli volunteers, more help is always required. Thus began the plan to invite foreign volunteers to assist in Hadassah’s Sharett Institute of Oncology.

READ MORE ›
alt_text

Tuesday, Aug 9 2016

Three-Prong Approach to Breast Cancer Research at Hadassah

Understanding what part inherited traits play in an individual’s chance of developing breast cancer; analyzing the specific biology of each tumor to better tailor therapy for each patient; and diagnosing cancer through blood samples, rather than performing biopsies, are the goals that are shaping the approach the Hadassah Medical Organization is taking to cancer research and treatment.

READ MORE ›

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Membership Questions

membership@hadassah.org

(800) 664-5646

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Missions Department

missions@hadassah.org

(800) 237-1517

Show More